Latest Growth hormone treatment Stories
Growth Hormones Direct releases Top 3 Reasons to diet with Growth Hormone in early spring. Phoenix, AZ (Vocus/PRWEB) March 11, 2011 Growth Hormones Direct releases the Top 3 reasons to diet with Growth Hormone in early spring. Top 3 Reasons to Diet with Growth Hormone in Early Spring: 1. The New Year's resolution to exercise more didn't result in weight loss (or more time at the gym). 2. Weight gain over the winter. 3. Upcoming swimsuit weather. Dr. J. Ronald Willis of Growth...
Growth Hormones Direct publishes video FAQs addressing topics such as, "What is Alpha GPC Growth Hormone?"Phoenix, AZ (Vocus/PRWEB) March 02, 2011 Growth Hormones Direct publishes video FAQs addressing topics such as, "What is Alpha GPC Growth Hormone?" Frequent questions such as this flow in through the company's email and phone customer service outlets. While every query is provided with an individual response in a timely manner, the company felt it would be beneficial...
Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.Disruption of a key protein in the pathway that responds to growth hormone could explain how fatty liver disease develops, the researchers said, but may also offer insights into how our bodies regulate fat in general.The team's findings and the first reports of a mouse model to...
Growth Hormones Direct published an article on the prevalence of genetic health risk factors, the role of homeopathic Growth Hormones therapy in decreasing health risks and the side effects of Growth Hormone therapy.Phoenix, AZ (Vocus/PRWEB) February 24, 2011 Growth Hormones Direct published an article on the prevalence of genetic health risk factors, the role of homeopathic Growth Hormones therapy in decreasing health risks and the side effects of Growth Hormone therapy. Many are aware of...
PRINCETON, N.J., Feb. 23, 2011 /PRNewswire/ -- Novo Nordisk announced today that a Biologic License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of a recombinant factor XIII compound (rFXIII) for the vast majority of patients with congenital factor XIII (FXIII) deficiency, an inherited bleeding disorder(1). The company anticipates filing its marketing authorization application to the European Medicines Agency in Q2 2011....
Growth Hormones Direct publishes glossary of terms for HGH related words like Growth Hormone releaser. Phoenix, AZ (Vocus/PRWEB) February 18, 2011 Growth Hormones Direct publishes glossary of terms for HGH related words like Growth Hormone releaser. The company added both articles and videos to their online database and YouTube channel with details about common terms in the industry and general definitions, etc. Consumers unsure of the meaning of terms that continually pop up in their...
As a child grows, a short stature is not usually cause for concern, but it is often the only sign of a condition called Turner syndrome. Prevalent in girls, Turner syndrome is a genetic defect that short-circuits normal growth and leads to cardiac and renal problems. It is not commonly detected until age 10 or older when a youngster's unusually short height raises suspicions.This lag before diagnosis of the condition can delay the start of growth hormone therapy, which can help in achieving...
Long-term study of remote community finds almost no cancer or diabetes in individuals with genetically low growth hormone activityA 22-year study of abnormally short individuals suggests that growth-stunting mutations also may stunt two of humanity's worst diseases.Published in Science Translational Medicine, part of the Science family of journals, the study raises the prospect of achieving similar protection in full-grown adults by other means, such as pharmaceuticals or controlled diets.The...
NES-ZIONA, Israel, Feb. 14, 2011 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, today reported that patient enrollment and dosing in the Phase II trial of its long-acting version of human growth hormone (hGH-CTP) are proceeding according to plan, with study completion targeted for mid-year 2011. The study is assessing the efficacy of hGH-CTP by measuring IGF-1 levels in growth hormone deficient adults in response...
PRINCETON, N.J., Feb. 4, 2011 /PRNewswire/ -- Novo Nordisk announced today the availability of Coags Uncomplicated - the first mobile application (app) to assist in the diagnosis of bleeding disorders - created in partnership with Craig Kessler, MD, Professor of Medicine and Pathology and Director of the Coagulation Laboratory, Georgetown University Hospital, Lombardi Comprehensive Cancer Center. Coags Uncomplicated features a Lab Value Analyzer that enables physicians to input test results...
